Frazier Life Sciences Management, L.P.

Position in EOLS — Evolus, Inc.

CIK 1892134 PALO ALTO, CA

Back to EOLS Full portfolio

Position in EOLS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$10,812,033

-$6,681,889 QoQ

Shares Held

2,630,665

0.0% QoQ

Ownership

3.99%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2025

4 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in EOLS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Frazier Life Sciences Management, L.P. holds $73,754,874 across 3 Drug Manufacturers - Specialty & Generic names. EOLS ranks #3 (14.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BCRX	Biocryst Pharmaceuticals Inc	4,009,240	$38,167,964
2	ALKS	Alkermes plc.	700,647	$24,774,877
3	EOLS	Evolus, Inc. This page	2,630,665	$10,812,033

All Filings in EOLS

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,812,033	2,630,665	0.0%	Shares	Sole	2026-05-15
2025-12-31	$17,493,922	2,630,665	0.0%	Shares	Sole	2026-02-13
2025-09-30	$16,152,283	2,630,665	+8.0%	Shares	Sole	2025-11-14
2025-06-30	$22,431,415	2,435,550	—	Shares	Sole	2025-08-14
No filing history on record for this holder in this stock.